Impact of chronic fluoxetine exposure on zebrafish: From fatty acid profile to behavior

Elsevier 2024-04-12

The consumption of antidepressants, such as fluoxetine, has increased over the years and, as a result, they are increasingly found in aquatic systems. Given the increasing use of zebrafish as an animal model in toxicological studies, this work proposed to evaluate the effects of chronic exposure, for 21 days, to fluoxetine at environmentally relevant concentrations (1, 10, 100, and 1000 ng/L). The behavioral tests performed did not reveal significant effects of fluoxetine. However, oxidative stress and changes in energy metabolism were detected after exposure to the highest concentrations of fluoxetine tested, namely a decrease in glutathione S-transferase (GST) activity (decrease of ca. 31%), increase in catalase (CAT) activity (increase of ca. 71%), and decrease in lactate dehydrogenase (LDH) activity (decrease of ca. 53%). Analysis of the fatty acid profile (FA) revealed a decrease in the omega-3 FA, docosahexaenoic acid (DHA), C22:6 (decrease in relative abundance between 6% and 8% for both the head and body), an increase in omega-6 FA, linoleic acid (LA), C18:2, (increased relative abundance between 8% and 11% in the head and between 5% and 9% in the body), which may suggest changes in the inflammatory state of these organisms. The integrated analysis adopted proved to be useful in detecting subindividual effects of fluoxetine and modes of action in fish.

Lipidomics; Biochemical biomarkers; Chronic effects; Environmental relevance; Fatty acids; artículo

Open access content. Open access content
embargoedAccess

English

CTK oai:digital.csic.es:10261/354462
Chemosphere 357: 142026 (2024)
00456535
10.1016/j.chemosphere.2024.142026
38615959
2-s2.0-85190354972
1431968352

CSIC
From OAIster®, provided by the OCLC Cooperative.

edsoai.on1431968352